However, even though the type of proteoglycans mediating the WISP1-induced expression of MIF is yet not clear, these chondroitin sulfate proteoglycans could be an excellent pharmacological target for various respiratory diseases in which the above molecules are implicated. The gene discussed is CCN4; the disease is respiratory system disorder.